Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Urological disorders are still the leading cause of inhospital death in patients with spina bifida.

Peyronnet B, Gao F, Brochard C, Oger E, Scailteux LM, Balusson F, Hascoet J, Alimi Q, Khene ZE, Bayat S, Jezequel M, Olivari C, Voiry C, Kerdraon J, Bouguen G, Game X, Siproudhis L, Manunta A.

Urology. 2019 Nov 14. pii: S0090-4295(19)30976-8. doi: 10.1016/j.urology.2019.11.006. [Epub ahead of print]

PMID:
31734348
3.

Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study.

Droitcourt C, Nowak E, Rault C, Happe A, Le Nautout B, Kerbrat S, Balusson F, Poizeau F, Travers D, Sapori JM, Lagarde E, Rey G, Guillot B, Oger E, Dupuy A.

Int J Epidemiol. 2019 Oct 1;48(5):1623-1635. doi: 10.1093/ije/dyz093.

4.

Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases.

George G, Scailteux LM, Garmo H, Balusson F, Cardwell C, Coster G, Schutter H, Kuiper JG, McMenamin Ú, Verbeeck J, Van Hemelrijck M.

Fundam Clin Pharmacol. 2019 Aug;33(4):479-499. doi: 10.1111/fcp.12454. Epub 2019 Mar 25.

5.

Major bleeding with antithrombotic agents: a 2012-2015 study using the French nationwide Health Insurance database linked to emergency department records within five areas - rationale and design of SACHA study.

Bouget J, Balusson F, Scailteux LM, Maignan M, Roy PM, L'her E, Pavageau L, Nowak E.

Fundam Clin Pharmacol. 2019 Aug;33(4):443-462. doi: 10.1111/fcp.12444. Epub 2019 Jan 11.

6.

French administrative health care database (SNDS): The value of its enrichment.

Scailteux LM, Droitcourt C, Balusson F, Nowak E, Kerbrat S, Dupuy A, Drezen E, Happe A, Oger E.

Therapie. 2019 Apr;74(2):215-223. doi: 10.1016/j.therap.2018.09.072. Epub 2018 Oct 25.

7.

Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study.

Scailteux LM, Rioux-Leclercq N, Vincendeau S, Balusson F, Nowak E, Oger E; Network of Pathologists in Brittany.

BJU Int. 2019 Feb;123(2):293-299. doi: 10.1111/bju.14495. Epub 2018 Sep 11.

8.
9.

Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data.

Scailteux LM, Vincendeau S, Balusson F, Leclercq C, Happe A, Le Nautout B, Polard E, Nowak E, Oger E.

Eur J Cancer. 2017 May;77:99-108. doi: 10.1016/j.ejca.2017.03.002. Epub 2017 Apr 5.

PMID:
28390298
10.

[Use of the PMSI for the detection of adverse drug reactions].

Osmont MN, Cuggia M, Polard E, Riou C, Balusson F, Oger E.

Therapie. 2013 Jul-Aug;68(4):285-95. doi: 10.2515/therapie/2013042. Epub 2013 Aug 28. French.

PMID:
23981266

Supplemental Content

Loading ...
Support Center